These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9352343)

  • 21. Antipsychotic drugs and relapse prevention.
    Marder SR
    Schizophr Res; 1999 Mar; 35 Suppl():S87-92. PubMed ID: 10190229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 1998 Nov; 13(6):253-62. PubMed ID: 9861575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical efficacy of olanzapine].
    Yui K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):101-10. PubMed ID: 10495984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
    Revicki DA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):110-7. PubMed ID: 11527002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of atypical antipsychotic drugs in patients with dementia.
    Motsinger CD; Perron GA; Lacy TJ
    Am Fam Physician; 2003 Jun; 67(11):2335-40. PubMed ID: 12800962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotic drugs and long-term outcome in schizophrenia.
    Weiden P; Aquila R; Standard J
    J Clin Psychiatry; 1996; 57 Suppl 11():53-60. PubMed ID: 8941171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia.
    Revicki DA
    Schizophr Res; 1999 Mar; 35 Suppl():S101-9. PubMed ID: 10190231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].
    Briken P; Nika E; Krausz M; Naber D
    Fortschr Neurol Psychiatr; 2002 Mar; 70(3):139-44. PubMed ID: 11880946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia treatment: the use of atypical drugs--risperdal, zyperexa, and clozaril.
    Kalinyak CM
    Int J Psychiatr Nurs Res; 1998 Sep; 4(2):445-51. PubMed ID: 10451301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad therapeutic uses of atypical antipsychotic medications.
    Buckley PF
    Biol Psychiatry; 2001 Dec; 50(11):912-24. PubMed ID: 11743945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
    Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
    Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment refractory schizophrenia: how should we proceed?
    Sharif ZA
    Psychiatr Q; 1998; 69(4):263-81. PubMed ID: 9793107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The promise of new drugs for schizophrenia treatment.
    Tamminga CA
    Can J Psychiatry; 1997 Apr; 42(3):265-73. PubMed ID: 9114942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atypical antipsychotic drugs].
    Kahn RS
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
    Voruganti L; Cortese L; Owyeumi L; Kotteda V; Cernovsky Z; Zirul S; Awad A
    Schizophr Res; 2002 Oct; 57(2-3):201-8. PubMed ID: 12223251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
    Geddes J; Freemantle N; Harrison P; Bebbington P
    BMJ; 2000 Dec; 321(7273):1371-6. PubMed ID: 11099280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.